Organon & Co. (OGN)
Pharmaceutical Preparations
Latest Price
$13.55
TTM P/E
14.41
Normalized P/E
4.52
Div Yield
0.59%
Book Value
3.47
P/B Ratio
3.91
Valuation metrics
adjust assumptions →EPS: $0.72
Book value / share: $2.89
Formula: √(22.5 × EPS × BVPS)
Graham Number
$6.84
50% downside
Norm. op. income: $1.3B (median of 5yr)
Tax rate: 18%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$10.60
22% downside
EPS: $0.72
Target P/E: 5×
Formula: EPS × P/E
P/E Fair Value
$3.60
73% downside
Institutional Ownership
73.3% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31.72M | $189.0M | 12.08% | +751.0K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 21.85M | $130.0M | 8.32% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 11.74M | $70.0M | 4.47% | -- | 2026-03-31 |
| STATE STREET CORP | 9.96M | $59.0M | 3.79% | +359.0K | 2026-03-31 |
| LSV ASSET MANAGEMENT | 7.26M | $43.0M | 2.76% | -212.7K | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 7.08M | $42.0M | 2.70% | +6.62M | 2026-03-31 |
| KAHN BROTHERS GROUP INC | 5.54M | $33.0M | 2.11% | +1.91M | 2026-03-31 |
| CANADA PENSION PLAN INVESTMENT BOARD | 5.01M | $30.0M | 1.91% | +2.58M | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 4.76M | $28.0M | 1.81% | +158.9K | 2026-03-31 |
| Think Investments LP | 4.00M | $23.0M | 1.52% | -- | 2026-03-31 |